ResearcherKeio UniversityNo recent work listed

Genta Ito

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5821-4242; OpenAlex author ID A5084440735. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper

Papers 1

Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy. Co-author DOI 10.1371/journal.pone.0254726 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Takashi Yokokawa · 1 shared paper, 2021 · strength 0.12
- Paper Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination t… DOI 10.1371/journal.pone.0254726 ↗
Satoko Hori · 1 shared paper, 2021 · strength 0.12
- Paper Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination t… DOI 10.1371/journal.pone.0254726 ↗
Masato Ozaka · 1 shared paper, 2021 · strength 0.12
- Paper Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination t… DOI 10.1371/journal.pone.0254726 ↗
Naoki Sasahira · 1 shared paper, 2021 · strength 0.12
- Paper Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination t… DOI 10.1371/journal.pone.0254726 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.